NANOMAB TECHNOLOGY LIMITED

City:

Central

Country:

Hong Kong

Published Applications:

Last publication date:

2023-08-24

Patent Grants:

Last grant date:

2024-09-10

Top Inventors for applications by NANOMAB TECHNOLOGY LIMITED

These are the the leading inventors for applications assigned to NANOMAB TECHNOLOGY LIMITED:

Chung Lim Wong 3 Shanghai, China
Hong Hoi Ting 3 Shanghai, China
Wenhua Huang 2 Shanghai, China

Recent patent applications by NANOMAB TECHNOLOGY LIMITED

NANOMAB TECHNOLOGY LIMITED based in Central, HK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-24 ✅ Patent 12,083,193 granted on 2024-09-10

US20230263916A1

Human necessities

Anti-Her2 nanobody and coding sequence and use thereof

#2 | 2020-10-01 ✅ Patent 11,517,632 granted on 2022-12-06

US20200306392A1

Human necessities

Anti-Her2 single chain antibody and coding sequence and use thereof

#3 | 2020-05-14 ✅ Patent 11,466,085 granted on 2022-10-11

US20200148772A1

Chemistry; metallurgy

Anti-PD-L1 nanobody, coding sequence and use thereof

Also check out NANOMAB TECHNOLOGY LIMITED's (Central, Hong Kong) applicant profile with 4 patent applications submitted.

AssigneeID:

387819 ⎘